Bríd Smith (Dublin South Central, People Before Profit Alliance)
Link to this: Individually | In context | Oireachtas source

215. To ask the Minister for Health the details of any studies completed by the HSE prior to the decision to discontinue reimbursement support for eye supplements from 2017. [38102/16]

Bríd Smith (Dublin South Central, People Before Profit Alliance)
Link to this: Individually | In context | Oireachtas source

216. To ask the Minister for Health the number of persons nationally that have applied via the discretionary hardship arrangement for continued support and reimbursements for eye supplements. [38103/16]

Bríd Smith (Dublin South Central, People Before Profit Alliance)
Link to this: Individually | In context | Oireachtas source

217. To ask the Minister for Health the number of persons nationally that have successfully received reimbursements via the discretionary hardship fund for eye supplements. [38104/16]

Bríd Smith (Dublin South Central, People Before Profit Alliance)
Link to this: Individually | In context | Oireachtas source

218. To ask the Minister for Health the criteria used by the operators of the discretionary hardship fund in assessing persons requests for continued reimbursement for eye supplements. [38105/16]

Bríd Smith (Dublin South Central, People Before Profit Alliance)
Link to this: Individually | In context | Oireachtas source

220. To ask the Minister for Health the projected savings to the HSE of the proposal to remove all eye supplements from its list of drugs qualifying for reimbursements in January 2017. [38107/16]

Simon Harris (Wicklow, Fine Gael)
Link to this: Individually | In context | Oireachtas source

I propose to take Questions Nos. 215 to 218, inclusive, and 220 together.

Under the Health (Pricing and Supply of Medical Goods) Act 2013, the HSE has statutory responsibility for the administration of the community drug schemes; therefore, the matter has been referred to the HSE for attention and direct reply.